Subject to share price and general market conditions, Anthony and Nick, for asset
diversification reasons, may sell up to 10% of their underlying individual shareholdings (less
than 2.5% of total issued capital) over the next twelve months.
I doubt it so how
- Forums
- ASX - By Stock
- APT
- Ann: Company Update
Ann: Company Update, page-5
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online